Some of them induce apoptosis, activate p53, and block cell cycle progression, limiting the growth of EBV-positive nasopharyngeal carcinoma cells [78,114,116,117,118,120,122,123,124,125,126,127,128,129]. Here, TP53 is linked to nasopharyngeal carcinoma.